AHNS Virtual Education Series: Ten Things I’ve Learned in Global Surgery

Presented by the AHNS Global Outreach Service

July 30, 2025

9:30 AM Eastern (US) / 7:00 PM Indian Standard Time / 1:00 PM GMT – Kumasi, Ghana

Moderator:

Pankaj Chaturvedi, MBBS – Tata Memorial Centre, Mumbai

Panelists:

Mark Prince, MD, FRCS(C), FACS – University of Michigan

Merry E. Sebelik, MD, FACS, MAMSE – Emory University

Curtis Hanba, MD, MS – University of Minnesota

Srini R. Chandra, BDS, MD, FDSRCS (Eng), FIBCSOMS (Onc-Recon) – Oregon Health & Science University

Anna Konney, MD, FWACS, FGPS – Komfo Anokye Teaching Hospital (KATH) – Kumasi Ghana

The expert panelists will briefly describe the current state of  Otolaryngology Global Surgery. Focus on practical solutions to incorporating global surgery into a career and opportunities to use a variety of already available sources to enhance education programs around the world. Importantly, the potential ethical issues that global surgery raises will be addressed. The information will be presented in a manner that stimulates audience participation and leverages novel ideas from the panelists and audience.

• Objective 1: Distinguish methods for integrating global surgery into a career
• Objective 2: Manage ethical challenges that arise in global surgery
• Objective 3: Solve equipment and support deficiencies in global work

Register Now!

The American Head and Neck Society (AHNS) strongly supports the continued and widespread use of the human papillomavirus (HPV) vaccine as a vital public health measure to prevent HPV-associated cancers, including oropharyngeal cancers—the most rapidly rising HPV-related malignancy in the United States.

Scientific evidence has consistently demonstrated that HPV vaccination is safe, effective, and significantly reduces the incidence of infections that lead to HPV-related cancers and papillomas. As experts in the care and treatment of head and neck cancers, the AHNS recognizes the critical role that vaccination plays in reducing the burden of HPV-related diseases and ultimately saving lives.

We advocate for HPV vaccination for all eligible individuals, as recommended by the Centers for Disease Control and Prevention (CDC). Vaccination is most effective when administered before exposure to the virus, typically in adolescence, but catch-up vaccination remains safe and potentially beneficial for many adults up to the age of 45.

The AHNS urges healthcare providers, policymakers, educators, and community leaders to support public health initiatives that expand access to and education about the HPV vaccine. Together, we can take meaningful steps toward the prevention of HPV-related cancers and the advancement of long-term public health.

Sincerely,

The American Head and Neck Society